Astera Labs (NASDAQ:ALAB) Updates Q1 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.530-0.540 for the period, compared to the consensus estimate of 0.430. The company issued revenue guidance of $286.0 million-$297.0 million, compared to the consensus revenue estimate of $260.1 million.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ALAB. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Raymond James Financial initiated coverage on Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Morgan Stanley reaffirmed an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Northland Securities lifted their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Finally, Citigroup reduced their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Astera Labs Stock Down 8.3%

NASDAQ ALAB traded down $11.92 during trading hours on Thursday, hitting $131.79. The company’s stock had a trading volume of 5,523,328 shares, compared to its average volume of 5,573,365. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The firm has a market capitalization of $22.26 billion, a P/E ratio of 108.27, a PEG ratio of 2.49 and a beta of 1.50. The stock has a fifty day moving average of $165.25 and a 200 day moving average of $174.42.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 576,936 shares of company stock valued at $87,409,540. Corporate insiders own 12.50% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 beat and record revenue — Astera reported $0.58 EPS vs. $0.51 consensus and $270.6M in revenue (≈92% YoY), plus record full‑year revenue. Results show strong AI demand and expanding margins. Press Release
• Positive Sentiment: High guidance — management guided Q1 revenue $286M–$297M and EPS $0.530–$0.540, both above Street assumptions, signaling continued hyperscaler demand. Guidance & Transcript
• Positive Sentiment: Analyst and market tailwinds — brokers point to exposure to Nvidia/AMD/Amazon/Google AI buildouts and see 2026 upside tied to data‑center AI infrastructure demand. Analyst Note
• Neutral Sentiment: Product ramp timing — management flagged Scorpio X volumes as modest in early‑2026 with meaningful ramps weighted to H2 and into 2027, implying near-term revenue mix/cadence uncertainty. Seeking Alpha
• Neutral Sentiment: Analyst target adjustments — Citi trimmed its price target from $275 to $250 but kept a buy rating, reflecting calibration of upside vs. valuation. Benzinga
• Neutral Sentiment: Corporate change — new CFO appointment announced (Desmond Lynch), with prior CFO moving to strategic advisor; transitions can create short‑term uncertainty. Press Release
• Negative Sentiment: Profit‑taking and valuation concerns — after a huge run to multi‑year highs, investors are locking gains; some analysts and commentaries call the stock richly valued and rate it a “hold,” prompting selling. Seeking Alpha
• Negative Sentiment: Big Amazon deal skepticism — coverage highlighted that a reported ~$6.5B chip/deal linkage could be a “double‑edged sword” (concentration and execution risk), which worried some investors. MarketWatch
• Negative Sentiment: Near‑term margin/expense concerns — management expects gross margin to step down slightly (~74%) as opex rises, and some coverage emphasized the outlook and timing of product ramps as reasons for the post‑earnings selloff. Seeking Alpha

Hedge Funds Weigh In On Astera Labs

Several hedge funds have recently made changes to their positions in ALAB. Fuller & Thaler Asset Management Inc. lifted its stake in Astera Labs by 6.7% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 823,573 shares of the company’s stock valued at $137,010,000 after purchasing an additional 51,651 shares during the last quarter. CIBC Private Wealth Group LLC increased its position in Astera Labs by 272.4% during the fourth quarter. CIBC Private Wealth Group LLC now owns 29,714 shares of the company’s stock worth $4,943,000 after buying an additional 21,735 shares during the last quarter. Wilmington Savings Fund Society FSB raised its stake in Astera Labs by 50.0% in the fourth quarter. Wilmington Savings Fund Society FSB now owns 11,250 shares of the company’s stock valued at $1,872,000 after buying an additional 3,750 shares during the period. Elo Mutual Pension Insurance Co acquired a new stake in shares of Astera Labs in the fourth quarter valued at approximately $4,170,000. Finally, Andra AP fonden acquired a new stake in shares of Astera Labs in the fourth quarter valued at approximately $5,857,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.